A Systematic Review of Severe Neurological Manifestations in Pediatric Patients with Coexisting SARS-CoV-2 Infection
SARS-CoV-2 infection in children produces mild respiratory symptoms or no symptoms at all in most cases. Some pediatric patients develop a severe complication associated with high mortality, the multisystem inflammatory syndrome in children (MIS-C). In both scenarios, there are reports of neurologic...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Neurology International |
Subjects: | |
Online Access: | https://www.mdpi.com/2035-8377/13/3/41 |
_version_ | 1797517827917217792 |
---|---|
author | Lauren O’Loughlin Nilo Alvarez Toledo Leon Budrie Randall Waechter Joanna Rayner |
author_facet | Lauren O’Loughlin Nilo Alvarez Toledo Leon Budrie Randall Waechter Joanna Rayner |
author_sort | Lauren O’Loughlin |
collection | DOAJ |
description | SARS-CoV-2 infection in children produces mild respiratory symptoms or no symptoms at all in most cases. Some pediatric patients develop a severe complication associated with high mortality, the multisystem inflammatory syndrome in children (MIS-C). In both scenarios, there are reports of neurological manifestations. This article aims to review the cases of pediatric patients with severe neurological issues and a coexisting positive SARS-CoV-2 test. A literature search was performed between March 2020 and May 2021. The results included the data from 41 studies, with 159 children with severe neurological manifestations, within an age range from 24 h to 17 years. The neurological disorders included 38 cases with stroke, 32 with encephalitis, 22 with encephalopathy, and 10 with Guillain–Barre syndrome. Sixty-five out of 159 cases with severe neurological manifestations were diagnosed with MIS-C. Direct neuroinvasion and the exaggerated immune response in some patients seem to be the most critical factors triggering these manifestations. Further research in the ongoing pandemic is needed to elucidate the precise mechanism. |
first_indexed | 2024-03-10T07:21:38Z |
format | Article |
id | doaj.art-cbf0e9fbd43a4d6cb45e74bb7ad3abf0 |
institution | Directory Open Access Journal |
issn | 2035-8377 |
language | English |
last_indexed | 2024-03-10T07:21:38Z |
publishDate | 2021-08-01 |
publisher | MDPI AG |
record_format | Article |
series | Neurology International |
spelling | doaj.art-cbf0e9fbd43a4d6cb45e74bb7ad3abf02023-11-22T14:33:36ZengMDPI AGNeurology International2035-83772021-08-0113341042710.3390/neurolint13030041A Systematic Review of Severe Neurological Manifestations in Pediatric Patients with Coexisting SARS-CoV-2 InfectionLauren O’Loughlin0Nilo Alvarez Toledo1Leon Budrie2Randall Waechter3Joanna Rayner4Department of Physiology, Neuroscience and Behavioral Sciences, School of Medicine, St. George’s University, St. George, GrenadaDepartment of Physiology, Neuroscience and Behavioral Sciences, School of Medicine, St. George’s University, St. George, GrenadaDepartment of Microbiology, Immunology and Pharmacology, School of Medicine, St. George’s University, St. George, GrenadaDepartment of Physiology, Neuroscience and Behavioral Sciences, School of Medicine, St. George’s University, St. George, GrenadaDepartment of Microbiology, Immunology and Pharmacology, School of Medicine, St. George’s University, St. George, GrenadaSARS-CoV-2 infection in children produces mild respiratory symptoms or no symptoms at all in most cases. Some pediatric patients develop a severe complication associated with high mortality, the multisystem inflammatory syndrome in children (MIS-C). In both scenarios, there are reports of neurological manifestations. This article aims to review the cases of pediatric patients with severe neurological issues and a coexisting positive SARS-CoV-2 test. A literature search was performed between March 2020 and May 2021. The results included the data from 41 studies, with 159 children with severe neurological manifestations, within an age range from 24 h to 17 years. The neurological disorders included 38 cases with stroke, 32 with encephalitis, 22 with encephalopathy, and 10 with Guillain–Barre syndrome. Sixty-five out of 159 cases with severe neurological manifestations were diagnosed with MIS-C. Direct neuroinvasion and the exaggerated immune response in some patients seem to be the most critical factors triggering these manifestations. Further research in the ongoing pandemic is needed to elucidate the precise mechanism.https://www.mdpi.com/2035-8377/13/3/41COVID-19coronavirusesneurological symptomspediatricsencephalitisanosmia |
spellingShingle | Lauren O’Loughlin Nilo Alvarez Toledo Leon Budrie Randall Waechter Joanna Rayner A Systematic Review of Severe Neurological Manifestations in Pediatric Patients with Coexisting SARS-CoV-2 Infection Neurology International COVID-19 coronaviruses neurological symptoms pediatrics encephalitis anosmia |
title | A Systematic Review of Severe Neurological Manifestations in Pediatric Patients with Coexisting SARS-CoV-2 Infection |
title_full | A Systematic Review of Severe Neurological Manifestations in Pediatric Patients with Coexisting SARS-CoV-2 Infection |
title_fullStr | A Systematic Review of Severe Neurological Manifestations in Pediatric Patients with Coexisting SARS-CoV-2 Infection |
title_full_unstemmed | A Systematic Review of Severe Neurological Manifestations in Pediatric Patients with Coexisting SARS-CoV-2 Infection |
title_short | A Systematic Review of Severe Neurological Manifestations in Pediatric Patients with Coexisting SARS-CoV-2 Infection |
title_sort | systematic review of severe neurological manifestations in pediatric patients with coexisting sars cov 2 infection |
topic | COVID-19 coronaviruses neurological symptoms pediatrics encephalitis anosmia |
url | https://www.mdpi.com/2035-8377/13/3/41 |
work_keys_str_mv | AT laurenoloughlin asystematicreviewofsevereneurologicalmanifestationsinpediatricpatientswithcoexistingsarscov2infection AT niloalvareztoledo asystematicreviewofsevereneurologicalmanifestationsinpediatricpatientswithcoexistingsarscov2infection AT leonbudrie asystematicreviewofsevereneurologicalmanifestationsinpediatricpatientswithcoexistingsarscov2infection AT randallwaechter asystematicreviewofsevereneurologicalmanifestationsinpediatricpatientswithcoexistingsarscov2infection AT joannarayner asystematicreviewofsevereneurologicalmanifestationsinpediatricpatientswithcoexistingsarscov2infection AT laurenoloughlin systematicreviewofsevereneurologicalmanifestationsinpediatricpatientswithcoexistingsarscov2infection AT niloalvareztoledo systematicreviewofsevereneurologicalmanifestationsinpediatricpatientswithcoexistingsarscov2infection AT leonbudrie systematicreviewofsevereneurologicalmanifestationsinpediatricpatientswithcoexistingsarscov2infection AT randallwaechter systematicreviewofsevereneurologicalmanifestationsinpediatricpatientswithcoexistingsarscov2infection AT joannarayner systematicreviewofsevereneurologicalmanifestationsinpediatricpatientswithcoexistingsarscov2infection |